I received a B.Sc. Hons. degree in Chemistry in 1987 and a Ph.D. in Physical Chemistry in 1990 from the Imperial College of Science, Technology and Medicine. I then held postdoctoral positions at (i) the Department of Biochemistry and the Centre for Molecular Recognition at the University of Cambridge (1990-93) and (ii) the Department of Biopharmaceutical Sciences and Pharmaceutical Chemistry at the University of California-San Francisco (1994-96). In 1996, I moved to the School of Pharmaceutical Sciences at the University of Geneva, where I was appointed to the position of Associate Professor in 2014 and was nominated as a Full Professor in 2022. I lead the “Molecular Therapeutics Delivery Group” and our focus is on (i) using formulation approaches and chemical and physical techniques to increase transport of low and high molecular weight therapeutics (e.g. peptides, proteins, antibodies, RNA) into and across biological barriers, (ii) the development of quantitative and qualitative methods to measure and to visualize the spatio-temporal biodistribution of drugs in the skin, the eye and the buccal mucosa and (iii) the use of ex vivo models to investigate drug uptake in the gastrointestinal tract and also drug disposition after subcutaneous injection.
